Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022
Nautilus Biotechnology, Inc. (NASDAQ: NAUT) will release its financial results for Q4 and the full year 2021 before the market opens on February 24, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Nautilus Biotechnology, Inc. (NASDAQ: NAUT) will release its financial results for Q4 and the full year 2021 before the market opens on February 24, 2022. The company's management will host a conference call at 5:30 a.m. PT / 8:30 a.m. ET to discuss these results along with updates on business developments and future outlook. Audio of the webcast will be accessible in the 'Investors' section of the Nautilus website.
Nautilus is focused on developing a single-molecule protein analysis platform aimed at advancing proteomics and improving healthcare.
Positive
- Scheduled financial results release indicating transparency and investor communication.
- Development in creating a single-molecule protein analysis platform has potential to transform proteomics.
Negative
- None.
Details
News Market Reaction – NAUT
The recorded move for NAUT in the trading session of this news was -6.75%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SEATTLE, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced it will report financial results for the fourth quarter and full year 2021 before market open on Thursday, February 24th, 2022.
The company’s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the “Investors” section of the company website at: www.nautilus.bio.
About Nautilus Biotechnology, Inc.
Based in Seattle, Washington, Nautilus is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio
Contacts
Investors:
InvestorRelations@nautilus.bio
Media:
Thermal for Nautilus Biotechnology
Kaustuva Das
Press@nautilus.bio
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.